Description
Recombinant monoclonal antibody to Tumor necrosis factor receptor superfamily member 4. Manufactured using AbAb’s Recombinant Platform with variable regions (i.e. specificity) from the hybridoma 20E5. This chimeric human antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques.
Target
Tumor necrosis factor receptor superfamily member 4
Target Alias Names
CD134, TNFRSF4, TXGP1L, ACT35 antigen, OX40L receptor, TAX transcriptionally-activated glycoprotein 1 receptor
Isotype/Mimetic
IgG1
Animal-Derived Biomaterials Used
No
Sequence Available
No
Original Discovery Method
recombinantly reformatted hybridoma (from pre-2020 immunisation)
Original Discovery Information Provided On Datasheet
Yes
Antibody/Binder Origins
Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression